Karunakaran Balaji1,2, Sitaraman Balaji Subramanian3, Krishnamoorthi Sathiya3, Moorthi Thirunavukarasu3, Chandrasekaran Anu Radha4, Velayudham Ramasubramanian4. 1. Department of Radiation Oncology, Gleneagles Global Hospitals, Chennai, Tamil Nadu, India. karthik.balaji85@gmail.com. 2. School of Advanced Sciences, Vellore Institute of Technology, Vellore, India. karthik.balaji85@gmail.com. 3. Department of Radiation Oncology, Gleneagles Global Hospitals, Chennai, Tamil Nadu, India. 4. School of Advanced Sciences, Vellore Institute of Technology, Vellore, India.
Abstract
OBJECTIVE: The aim of this study was to assess the feasibility of flattening filter-free (FFF) photon beams in hybrid intensity-modulated radiation therapy (H-IMRT) and hybrid volumetric modulated arc therapy (H-VMAT) for left-sided whole-breast radiation therapy with a boost volume (RT) using a hypofractionated dose regimen. PATIENTS AND METHODS: RT plans of 25 patients with left-sided early-stage breast cancer were created with H‑IMRT and H‑VMAT techniques under breath-hold conditions using 6‑MV FFF beams. In hybrid techniques, three-dimensional conformal radiotherapy (3DCRT) plans were kept as base-dose plans for the VMAT and IMRT plans. In addition, H‑IMRT in step-and-shoot mode was also calculated to assess its achievability with FFF beams. RESULTS: All hybrid plans achieved the expected target coverage. H‑VMAT showed better coverage and homogeneity index results for the boost target (p < 0.002), while H‑IMRT presented better results for the whole-breast target (p < 0.001). Mean doses to normal tissues were comparable between both plans, while H‑IMRT reduced the low-dose levels to heart and ipsilateral lung (p < 0.05). H‑VMAT revealed significantly better results with regard to monitor units (MU) and treatment time (p < 0.001). CONCLUSION: The 6‑MV FFF beam technique is feasible for large-field 3DCRT-based hybrid planning in whole-breast and boost planning target volume irradiation. For breath-hold patients, the H‑VMAT plan is superior to H‑IMRT for hypofractionated dose regimens, with reduced MU and treatment delivery time.
OBJECTIVE: The aim of this study was to assess the feasibility of flattening filter-free (FFF) photon beams in hybrid intensity-modulated radiation therapy (H-IMRT) and hybrid volumetric modulated arc therapy (H-VMAT) for left-sided whole-breast radiation therapy with a boost volume (RT) using a hypofractionated dose regimen. PATIENTS AND METHODS: RT plans of 25 patients with left-sided early-stage breast cancer were created with H‑IMRT and H‑VMAT techniques under breath-hold conditions using 6‑MV FFF beams. In hybrid techniques, three-dimensional conformal radiotherapy (3DCRT) plans were kept as base-dose plans for the VMAT and IMRT plans. In addition, H‑IMRT in step-and-shoot mode was also calculated to assess its achievability with FFF beams. RESULTS: All hybrid plans achieved the expected target coverage. H‑VMAT showed better coverage and homogeneity index results for the boost target (p < 0.002), while H‑IMRT presented better results for the whole-breast target (p < 0.001). Mean doses to normal tissues were comparable between both plans, while H‑IMRT reduced the low-dose levels to heart and ipsilateral lung (p < 0.05). H‑VMAT revealed significantly better results with regard to monitor units (MU) and treatment time (p < 0.001). CONCLUSION: The 6‑MV FFF beam technique is feasible for large-field 3DCRT-based hybrid planning in whole-breast and boost planning target volume irradiation. For breath-hold patients, the H‑VMAT plan is superior to H‑IMRT for hypofractionated dose regimens, with reduced MU and treatment delivery time.
Entities:
Keywords:
Breast neoplasms; Photons; Radiation dose hypofractionation; Radiotherapy; Radiotherapy, intensity-modulated
Authors: Rajiv K Agrawal; Abdulla Alhasso; Peter J Barrett-Lee; Judith M Bliss; Peter Bliss; David Bloomfield; Joanna Bowen; A Murray Brunt; Ellen Donovan; Marie Emson; Andrew Goodman; Adrian Harnett; Joanne S Haviland; Ronald Kaggwa; James P Morden; Anne Robinson; Sandra Simmons; Alan Stewart; Mark A Sydenham; Isabel Syndikus; Jean Tremlett; Yat Tsang; Duncan Wheatley; Karen Venables; John R Yarnold Journal: Radiother Oncol Date: 2011-07 Impact factor: 6.280
Authors: Melissa L James; Margot Lehman; Phil N Hider; Mark Jeffery; Daniel P Francis; Brigid E Hickey Journal: Cochrane Database Syst Rev Date: 2008-07-16
Authors: Enja J Bantema-Joppe; Eline J Vredeveld; Geertruida H de Bock; Dianne M Busz; Marleen Woltman-van Iersel; Wil V Dolsma; Hans Paul van der Laan; Johannes A Langendijk; John H Maduro Journal: Radiother Oncol Date: 2013-09-19 Impact factor: 6.280
Authors: S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold Journal: Lancet Date: 2008-03-19 Impact factor: 79.321
Authors: Alexander Venjakob; Michael Oertel; Dominik Alexander Hering; Christos Moustakis; Uwe Haverkamp; Hans Theodor Eich Journal: Strahlenther Onkol Date: 2020-10-17 Impact factor: 3.621